Nov 14, 2023
53:50
For every 50 shares held, investors received 53. The price per share adjusted from $0.31 to $0.29.
The split itself did not change the total investment value.
Ceryvyn Therapeutics Ltd (CKDXF) trades on the Other OTC in the Biotechnology industry.
Ceryvyn Therapeutics Ltd company overviewThe latest split shown was on November 14, 2023. It was a 53-for-50 forward split, so shareholders received 53 shares for every 50 they held.
This history records one forward split, on November 14, 2023.
Already premium? Sign in